SBK harnesses its industry-leading AI-powered metabolic research platform to integrate cutting-edge global R&D breakthroughs. Through multi-dimensional data modeling, it precisely identifies clinical metabolic deficiencies in drug candidates. Centered on an AI-driven drug metabolism analysis and intelligent design system, the platform dynamically collects cross-species metabolic data to build a comprehensive AI-powered metabolic database, enabling end-to-end R&D iteration from early discovery to clinical translation. This approach targets unmet clinical needs and delivers innovative therapies with precision.

With a focus on the respiratory field, we are dedicated to developing the world’s most advanced, metabolically differentiated therapies. Several products are already in clinical trial stages.

With a focus on cardiovascular and cerebrovascular diseases, we are committed to developing the world’s most advanced and differentiated therapies in cardiovascular metabolism. Several products are already in clinical trial stages.